The trial evaluates tafenoquine's efficacy for severe babesiosis, led by Brigham and Women’s Hospital, involving multiple clinical sites.Quiver AI Summary60 Degrees Pharmaceuticals, Inc. has announced...
ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (Nasdaq:VSEE) and 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP) on the RedChip Small Stocks, Big...
ORLANDO, FL / ACCESSWIRE / November 22, 2024 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP) and Can-Fite BioPharma Ltd. (NYSE American:CANF)(TASE:CANF) on the...
60 Degrees Pharmaceuticals reported Q3 2024 revenue of $135,000, a 164% increase, with improved gross profit and rising expenses.Quiver AI Summary60 Degrees Pharmaceuticals, Inc. reported a significant...
/PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that 60 Degrees...